Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

NCT03370718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Carcinoma in the Adrenal Cortex
Stage III Adrenal Cortex Carcinoma AJCC v8
Stage IV Adrenal Cortex Carcinoma AJCC v8
Unresectable Adrenal Cortex Carcinoma

Interventions

DRUG: Cabozantinib
OTHER: Pharmacogenomic Study
OTHER: Pharmacokinetic Study

Sponsor

M.D. Anderson Cancer Center